• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

抗凝难治性卒中与选择性梗死模式：有何关联？

Anticoagulation-refractory strokes and selective infarction pattern: What's the link?

作者信息

Dimancea Alexandru, Ene Amalia, Badea Raluca, Ribigan Athena

机构信息

Neurology Department Bucharest University Emergency Hospital Bucharest Romania.

出版信息

Clin Case Rep. 2020 Dec 8;9(1):220-223. doi: 10.1002/ccr3.3502. eCollection 2021 Jan.

DOI:10.1002/ccr3.3502
PMID:33489163
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7813005/
Abstract

Stroke etiology in the form of a CAP should be actively explored, especially in the context of previous negative work-up and anticoagulant-refractory strokes. Dual antiplatelet therapy proved superior to anticoagulation for secondary prevention.

摘要

应积极探索心源性栓塞形式的卒中病因，尤其是在既往检查结果为阴性和抗凝治疗难治性卒中的情况下。双重抗血小板治疗在二级预防方面被证明优于抗凝治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/7813005/853071687aa4/CCR3-9-220-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/7813005/f867b943778e/CCR3-9-220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/7813005/853071687aa4/CCR3-9-220-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/7813005/f867b943778e/CCR3-9-220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/900f/7813005/853071687aa4/CCR3-9-220-g002.jpg

相似文献

1
Anticoagulation-refractory strokes and selective infarction pattern: What's the link?抗凝难治性卒中与选择性梗死模式：有何关联？
Clin Case Rep. 2020 Dec 8;9(1):220-223. doi: 10.1002/ccr3.3502. eCollection 2021 Jan.
2
A Case of Failed Dual Antiplatelet Therapy With Oral Anticoagulant in the Prevention of Acute Ischemic Stroke.口服抗凝剂联合双重抗血小板治疗预防急性缺血性卒中失败1例
Cureus. 2021 Jun 25;13(6):e15915. doi: 10.7759/cureus.15915. eCollection 2021 Jun.
3
Complex atheromatosis of the aortic arch in cerebral infarction.脑梗死中主动脉弓的复杂性动脉粥样硬化病变
Curr Cardiol Rev. 2010 Aug;6(3):184-93. doi: 10.2174/157340310791658712.
4
Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?隐源性卒中与卵圆孔未闭：正确的治疗方法是什么？
Am J Med. 2016 Nov;129(11):1159-1162. doi: 10.1016/j.amjmed.2016.08.006. Epub 2016 Aug 24.
5
Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines.当代抗血小板和抗凝治疗用于二级卒中预防：当前文献和指南的叙述性综述。
Curr Neurol Neurosci Rep. 2023 May;23(5):235-262. doi: 10.1007/s11910-023-01266-2. Epub 2023 Apr 11.
6
[Anticoagulation status and adherence in patients with atrial fibrillation hospitalized for ACS and the impact on 1-year prognosis: a multicenter cohort study].[急性冠状动脉综合征住院房颤患者的抗凝状态、依从性及其对1年预后的影响：一项多中心队列研究]
Zhonghua Xin Xue Guan Bing Za Zhi. 2023 Jul 24;51(7):731-741. doi: 10.3760/cma.j.cn112148-20230314-00138.
7
Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection: The STOP-CAD Study.颈动脉夹层卒中预防的抗栓治疗：STOP-CAD 研究。
Stroke. 2024 Apr;55(4):908-918. doi: 10.1161/STROKEAHA.123.045731. Epub 2024 Feb 9.
8
Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome.抗磷脂综合征缺血性脑卒中患者二级预防中单联抗血小板与双联抗血小板抗凝治疗的比较。
Int J Med Sci. 2009 Dec 5;7(1):15-8. doi: 10.7150/ijms.7.15.
9
Intraluminal Thrombus of the Extracranial Cerebral Arteries in Acute Ischemic Stroke: Manifestations, Treatment Strategies, and Outcome.急性缺血性脑卒中颅外脑动脉腔内血栓：表现、治疗策略和结局。
Vasc Health Risk Manag. 2024 Jan 3;20:1-12. doi: 10.2147/VHRM.S435227. eCollection 2024.
10
Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin.维生素K拮抗剂与抗血小板治疗用于动脉源性短暂性脑缺血发作或轻度缺血性卒中后
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD001342. doi: 10.1002/14651858.CD001342.pub3.

本文引用的文献

1
Structure and Function of the Left Atrium and Left Atrial Appendage: AF and Stroke Implications.左心房和左心耳的结构和功能：房颤和卒中的影响。
J Am Coll Cardiol. 2017 Dec 26;70(25):3157-3172. doi: 10.1016/j.jacc.2017.10.063.
2
Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.氯吡格雷联合阿司匹林与华法林治疗合并主动脉弓斑块的缺血性脑卒中患者的疗效比较
Stroke. 2014 May;45(5):1248-57. doi: 10.1161/STROKEAHA.113.004251. Epub 2014 Apr 3.
3
Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation: a systematic review and analysis of observational studies.
经皮左心耳封堵术预防非瓣膜性心房颤动患者卒中：系统评价和观察性研究分析。
JACC Cardiovasc Interv. 2014 Mar;7(3):296-304. doi: 10.1016/j.jcin.2013.11.010.
4
Apixaban versus warfarin in patients with atrial fibrillation.阿哌沙班与华法林用于房颤患者。
N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.
5
Complex atheromatosis of the aortic arch in cerebral infarction.脑梗死中主动脉弓的复杂性动脉粥样硬化病变
Curr Cardiol Rev. 2010 Aug;6(3):184-93. doi: 10.2174/157340310791658712.
6
New anticoagulants: how to deal with treatment failure and bleeding complications.新型抗凝药物：如何应对治疗失败和出血并发症。
Br J Clin Pharmacol. 2011 Oct;72(4):593-603. doi: 10.1111/j.1365-2125.2011.04060.x.
7
Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel.华法林等香豆素衍生物的口服抗凝作用和氯吡格雷的抗血小板作用。
Eur Heart J. 2010 May;31(10):1205-11. doi: 10.1093/eurheartj/ehq023. Epub 2010 Feb 16.
8
Dabigatran versus warfarin in patients with atrial fibrillation.达比加群与华法林用于房颤患者的比较。
N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30.
9
Aortic atherosclerotic disease and stroke.主动脉粥样硬化疾病与中风。
Circulation. 2006 Jul 4;114(1):63-75. doi: 10.1161/CIRCULATIONAHA.105.593418.
10
Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque.治疗对519例严重胸主动脉斑块患者中风及其他栓子发生率的影响。
Am J Cardiol. 2002 Dec 15;90(12):1320-5. doi: 10.1016/s0002-9149(02)02870-9.